Oseltamivir News and Research

RSS
Flu deaths analyzed for future lessons

Flu deaths analyzed for future lessons

Daiichi Sankyo launches Inavir inhalation powder in Japan

Daiichi Sankyo launches Inavir inhalation powder in Japan

BioCryst to present intravenous peramivir data for influenza treatment at IDSA meeting

BioCryst to present intravenous peramivir data for influenza treatment at IDSA meeting

Gilead Sciences third quarter total revenues increase 8% to $1.94 billion

Gilead Sciences third quarter total revenues increase 8% to $1.94 billion

Oseltamivir reduces mortality in influenza A/H5N1 patients

Oseltamivir reduces mortality in influenza A/H5N1 patients

CDC issues new universal influenza vaccination recommendation for all Americans

CDC issues new universal influenza vaccination recommendation for all Americans

News outlets look at how H1N1 will inform WHO's future outbreak response

News outlets look at how H1N1 will inform WHO's future outbreak response

Emergency Committee Members report on post-pandemic period of H1N1

Emergency Committee Members report on post-pandemic period of H1N1

Gilead Sciences second-quarter total revenues increase 17% to $1.93 billion

Gilead Sciences second-quarter total revenues increase 17% to $1.93 billion

New development in flu prevention & treatment

New development in flu prevention & treatment

Study reveals asthma as a risk factor for pneumonia in children hospitalized for influenza

Study reveals asthma as a risk factor for pneumonia in children hospitalized for influenza

Preclinical study shows treatment with DAS181 inhibits infection with multiple HPIV strains

Preclinical study shows treatment with DAS181 inhibits infection with multiple HPIV strains

Fraudulent Tamiflu sold over Internet, FDA warns

Fraudulent Tamiflu sold over Internet, FDA warns

Caltech biologists pinpoint molecular changes that help allow global spread of resistance to Tamiflu

Caltech biologists pinpoint molecular changes that help allow global spread of resistance to Tamiflu

Antiviral drug oseltamivir appears safe and effective for infants hospitalized with influenza: Study

Antiviral drug oseltamivir appears safe and effective for infants hospitalized with influenza: Study

Pregnant women with H1N1 flu strain are at risk for obstetrical complications: Study

Pregnant women with H1N1 flu strain are at risk for obstetrical complications: Study

Influenza antiviral drugs not hoarded during recent H1N1 flu season, says Prime Therapeutics

Influenza antiviral drugs not hoarded during recent H1N1 flu season, says Prime Therapeutics

Adamas Pharmaceuticals presents study results of TCAD therapy in immunocompromised influenza A patients

Adamas Pharmaceuticals presents study results of TCAD therapy in immunocompromised influenza A patients

Preclinical study of DAS181 for treatment and prevention of ILI published

Preclinical study of DAS181 for treatment and prevention of ILI published

Antiviral treatment may lead to drug-resistant H1N1 virus: NIAID

Antiviral treatment may lead to drug-resistant H1N1 virus: NIAID